What does Renal Cell Carcinoma (RCC) with stents in place mean?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding RCC and Stents in Place

Renal Cell Carcinoma (RCC) with stents in place refers to a patient with kidney cancer who has had stents inserted to maintain the patency of vessels or ducts that may be obstructed by the tumor or its treatment effects. 1, 2

Types of Stents in RCC Patients

  • Ureteral stents: Commonly placed to relieve urinary obstruction caused by the tumor pressing on the ureter, ensuring continued drainage of urine from the kidney to the bladder 3
  • Vascular stents: May be placed to maintain blood flow in vessels compressed by the tumor, such as renal artery stents or inferior vena cava stents in cases of venous tumor thrombus 3, 2
  • Biliary stents: Less commonly needed in RCC but may be used if there is metastatic disease causing biliary obstruction 3

Clinical Significance of Stents in RCC

  • Symptom management: Stents provide rapid relief of symptoms caused by obstruction, such as pain, swelling, or impaired organ function 3
  • Preservation of renal function: Ureteral stents help maintain kidney function by ensuring continued urinary drainage, which is critical for patients who may need nephron-sparing approaches 3, 1
  • Facilitation of treatment: Stents may be placed before or during surgical intervention for RCC, particularly in cases with venous tumor thrombus (common in T3 disease) 2
  • Palliative care: In advanced or metastatic RCC, stents may be placed to alleviate symptoms and improve quality of life even when curative treatment is not possible 3

Management Considerations for RCC Patients with Stents

  • Regular monitoring: Patients with stents require regular follow-up to assess stent patency and function, typically with imaging studies 3
  • Stent exchange: Ureteral stents typically need replacement every 3-6 months to prevent encrustation, infection, or obstruction 3
  • Anticoagulation: Patients with vascular stents may require anticoagulation therapy, which must be carefully managed in the context of potential surgical interventions 3, 2
  • Infection prevention: Patients with stents have an increased risk of infection and should be monitored for signs of infection such as fever, pain, or changes in urine 3

Common Pitfalls and Considerations

  • Stent complications: Be vigilant for complications such as migration, occlusion, or infection, which may require prompt intervention 3
  • Stent-related symptoms: Patients may experience discomfort, urinary frequency, or hematuria related to the stent itself, which should be distinguished from disease progression 3
  • Treatment planning: The presence of stents must be considered when planning further treatments, including systemic therapy or surgery 2
  • Long-term management: For patients with non-removable stents, long-term management strategies should be implemented, including regular imaging surveillance and prompt attention to any new symptoms 3

Prognostic Implications

  • The need for stenting in RCC patients often indicates locally advanced disease (such as T3 tumors with venous involvement) or complications from the tumor, which may affect overall prognosis 2, 4
  • However, successful stenting can improve quality of life and may enable patients to receive further treatments that could improve survival outcomes 3, 1

References

Guideline

Renal Cell Carcinoma Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Stage T3 Clear Cell Renal Cell Carcinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.